Envionmental, Social and corporate Governance (ESG) investors should take into account all the good that biotechnolgy is doing, BIO President and CEO Dr. Michelle McMurry-Heath writes in an op-ed in Fortune.
“Investors might be drawn to familiar green industries like electric vehicles or solar panel manufacturers, or explicitly socially conscious brands like Salesforce.com. However, many of the most valuable ESG investments are in more fundamental sectors: software companies that have gone carbon-neutral, cutting-edge waste management firms, and especially the diverse firms of the biosciences industry,” she explains.
